First Horizon Advisors’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.88K | Sell |
446
-349
| -44% | -$2.53K | ﹤0.01% | 1893 |
|
|
2025
Q1 | $6.33K | Sell |
795
-21
| -3% | -$212 | ﹤0.01% | 1747 |
|
|
2024
Q4 | $7.42K | Buy |
+816
| New | +$7.88K | ﹤0.01% | 1701 |
|
|
2024
Q3 | – | Sell |
-791
| Closed | -$7.74K | – | 2395 |
|
|
2024
Q2 | $7.74K | Sell |
791
-1,466
| -65% | -$17.9K | ﹤0.01% | 1635 |
|
|
2024
Q1 | $34.1K | Sell |
2,257
-264
| -10% | -$4.79K | ﹤0.01% | 1131 |
|
|
2023
Q4 | $54.3K | Sell |
2,521
-620
| -20% | -$11.4K | ﹤0.01% | 902 |
|
|
2023
Q3 | $58.4K | Sell |
3,141
-1,212
| -28% | -$28.3K | ﹤0.01% | 794 |
|
|
2023
Q2 | $110K | Sell |
4,353
-573
| -12% | -$14.4K | ﹤0.01% | 618 |
|
|
2023
Q1 | $128K | Buy |
4,926
+1,652
| +50% | +$44.2K | ﹤0.01% | 580 |
|
|
2022
Q4 | $77.4K | Sell |
3,274
-1,084
| -25% | -$29.2K | ﹤0.01% | 698 |
|
|
2022
Q3 | $109K | Sell |
4,358
-139
| -3% | -$4.88K | ﹤0.01% | 580 |
|
|
2022
Q2 | $149K | Buy |
4,497
+4,471
| +17,196% | +$190K | 0.01% | 532 |
|
|
2022
Q1 | $2K | Sell |
26
-2,099
| -99% | -$151K | ﹤0.01% | 1480 |
|
|
2021
Q4 | $194K | Buy |
2,125
+406
| +24% | +$48.5K | 0.01% | 504 |
|
|
2021
Q3 | $217K | Buy |
1,719
+446
| +35% | +$64.9K | 0.01% | 485 |
|
|
2021
Q2 | $211K | Buy |
1,273
+745
| +141% | +$121K | 0.01% | 394 |
|
|
2021
Q1 | $95K | Buy |
528
+488
| +1,220% | +$113K | 0.01% | 523 |
|
|
2020
Q4 | $7K | Sell |
40
-125
| -76% | -$25.4K | ﹤0.01% | 1153 |
|
|
2020
Q3 | $35K | Buy |
165
+27
| +20% | +$5.72K | ﹤0.01% | 645 |
|
|
2020
Q2 | $25K | Sell |
138
-291
| -68% | -$51K | ﹤0.01% | 723 |
|
|
2020
Q1 | $65K | Sell |
429
-284
| -40% | -$33K | 0.01% | 433 |
|
|
2019
Q4 | $58K | Sell |
713
-145
| -17% | -$11K | ﹤0.01% | 539 |
|
|
2019
Q3 | $57K | Buy |
858
+139
| +19% | +$9.15K | ﹤0.01% | 524 |
|
|
2019
Q2 | $47K | Buy |
719
+325
| +82% | +$18.9K | ﹤0.01% | 590 |
|
|
2019
Q1 | $21K | Hold |
394
| – | – | ﹤0.01% | 822 |
|
|
2018
Q4 | $19K | Buy |
394
+118
| +43% | +$7.22K | ﹤0.01% | 816 |
|
|
2018
Q3 | $23K | Hold |
276
| – | – | ﹤0.01% | 840 |
|
|
2018
Q2 | $16K | Hold |
276
| – | – | ﹤0.01% | 982 |
|
|
2018
Q1 | $11K | Hold |
276
| – | – | ﹤0.01% | 971 |
|
|
2017
Q4 | $9K | Buy |
276
+147
| +114% | +$4.88K | ﹤0.01% | 1067 |
|
|
2017
Q3 | $4K | Hold |
129
| – | – | ﹤0.01% | 1224 |
|
|
2017
Q2 | $4K | Buy |
+129
| New | +$3.76K | ﹤0.01% | 1211 |
|
Other funds holding TDOC
MRCP
First Horizon Advisors's TDOC Position: Q2 2025 in Review
First Horizon Advisors reduced its Teladoc Health (TDOC) stake by 44% in Q2 2025, selling an estimated $2.53K and leaving 446 shares worth $3.88K. The position accounts for ﹤0.01% of the portfolio, ranked #1893.
First Horizon Advisors first reported a position in TDOC in Q2 2017 and has held it in 32 quarters since. The position peaked at $217K in Q3 2021. 359 funds tracked by Wall St. Rank hold TDOC as of Q2 2025.
- First Horizon Advisors held 446 shares of Teladoc Health worth $3.88K as of Q2 2025.
- First Horizon Advisors sold 349 Teladoc Health shares in Q2 2025, an estimated $2.53K.
- Teladoc Health made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1893 holding.
- First Horizon Advisors first reported a position in Teladoc Health in Q2 2017 and has held it in 32 quarters since.
- First Horizon Advisors's Teladoc Health position peaked at $217K in Q3 2021.
- 359 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.